Gennao Bio Presents New Data on Novel Gene Monoclonal Antibody Platform Technology at the American Association for Cancer Research (AACR) 2021 Annual Meeting

NEXT STORY
HOOKIPA announces positive preliminary Phase 1 immunogenicity data for its immunotherapy candidates to treat advanced HPV16+ cancers
PREV STORY
Valneva Announces Publication of 2020 Universal Registration Document and Provides Business Updates
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Terry Bradshaw Encourages Patients to “Take the Pledge to Live Well” in New PSA about Rheumatic Disease

Atlanta, Aug. 23, 2018 (GLOBE NEWSWIRE) -- This September, Sports Broadcaster Terry Bradshaw is ...

author_avatar
NASDAQ Market News

Basilea licenses late-stage oncology drug candidate derazantinib from ArQule

author_avatar
NASDAQ Market News

AVISE® Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive SLE Diagnosis and Positively Impacts Treatment Decisions

author_avatar
NASDAQ Market News